Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5

Journal of Neurochemistry

Volumn 88, Issue 2, 2004, Pages 298-310

  Gong, Cheng Xin ^a   Liu, Fei ^a   Wu, Guoxin ^a   Rossie, Sandra ^b   Wegiel, Jerzy ^a   Li, Liang ^a,c   Grundke Iqbal, Inge ^a   Iqbal, Khalid ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b PURDUE UNIVERSITY   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Dephosphorylation; Hyperphosphorylation; Protein phosphatase 5; Tau

Indexed keywords

ARACHIDONIC ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 5; PHOSPHOSERINE; PHOSPHOTHREONINE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CADAVER; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; MAMMAL; MICROTUBULE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALIA; MAMMALIA;

EID: 0345825934     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02147.x     Document Type: Article

References (75)

1. Abraha A., Ghoshal N., Gamblin T. C., Cryns V., Berry R. W., Kuret J. and Binder L. I. (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J. Cell Sci. 113, 3737-3745.
2. Alonso A. del C., Zaidi T., Grundke-Iqbal I. and IqbaI K. (1994) Role of abnormally phosphorylated τ in the breakdown of microtubules in Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 5562-5566.
3. Alonso A. del C., Zaidi T., Novak M., Grundke-Iqbal I. and Iqbal K. (2001a) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl Acad. Sci. USA 98, 6923-6928.
4. Alonso A. del C., Zaidi T., Novak M., Barra H. S., Grundke-Iqbal I. and Iqbal K. (2001b) Interaction of tau isoforms with Alzheimer disease abnormally hyperphosphorylated tau and in vitro phosphorylation into disease like protein. J. Biol. Chem. 276, 37967-37973.
5. Andreeva A. V. and Kutuzov M. S. (1999) Non-classical protein Ser/Thr phosphatases: What are they for? Biochem. (Moscow) 64, 228-234.
6. Bahl R., Bradley K. C., Thompson K. J., Swain R. A., Rossie S. and Meisel R. L. (2001) Localization of protein Ser/Thr phosphatase 5 in rat brain. Brain Res. Mol. Brain Res. 90, 101-109.
7. Becker W., Kentrup H., Klumpp S., Schultz J. E. and Joost H. G. (1994) Molecular cloning of a protein serine/threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. J. Biol. Chem. 269, 22586-22592.
8. Becker W., Buttini M., Limonta S., Boddeke H. and Joost H. G. (1996) Distribution of the mRNA for protein phosphatase T in rat brain. Brain Res. Mol. Brain Res. 36, 23-28.
9. Bennecib M., Gong C.-X., Grundke-Iqbal I. and Iqbal K. (2000) Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett. 485, 87-93.
10. Bennecib M., Gong C.-X., Grundke-Iqbal I. and Iqbal K. (2001) Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett. 490, 15-22.
11. Borthwick E. B., Zeke T., Prescott A. R. and Cohen P. T. (2001) Nuclear localization of protein phosphatase 5 is dependent on the carboxy-terminal region. FEBS Lett. 491, 279-284.
12. Braak E., Braak H. and Mandelkow E.-M. (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropath. 87, 554-567.
13. Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q. and Lee V. M. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089-1099.
14. Chen M. X. and Cohen P. T. W. (1997) Activation of protein phosphatase 5 by limited proteolysis or the binding of polyunsaturated fatty acids to the TPR domain. FEBS Lett. 400, 136-140.
15. Chen M. X., McPartlin A. E., Brown L., Chen Y. H., Barker H. M. and Cohen P. T. W. (1994) A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J. 13, 4278-4290.
16. Chinkers M. (1994) Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. Proc. Natl Acad. Sci. USA 91, 11075-11079.
17. Chinkers M. (2001) Protein phosphatase 5 in signal transduction. Trends Endocrinol. Metab. 12, 28-32.
18. Cohen P. (1973) The subunit structure of rabbit-skeletal-muscle phosphorylase kinase, and the molecular basis of its activation reactions. Eur. J. Biochem. 34, 1-14.
19. Cohen P. (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453-508.
20. Cohen P. T. W., Chen M. X. and Armstrong C. G. (1996) Novel protein phosphatases that may participate in cell signaling. Adv. Pharmacol. 36, 67-89.
21. Dean D. A., Urban G., Aragon I. V., Swingle M., Miller B., Rusconi S., Bueno M., Dean N. M. and Honkanen R. E. (2001) Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biol. 2, 6.
22. Drewes G., Mandelkow E. M., Baumann K., Goris J., Merlevede W. and Mandelkow E. (1993) Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Lett. 336, 425-432.
23. Galigniana M. D., Harrell J. M., Murphy P. J., Chinkers M., Radanyi C., Renoir J. M., Zhang M. and Pratt W. B. (2002) Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain. Biochemistry 41, 13602-13610.
24. Gamblin T. C., Berry R. W. and Binder L. I. (2003) Tau polymerization: role of the amino terminus. Biochemistry 42, 2252-2257.
25. Godemann R., Biemat J., Mandelkow E. and Mandelkow E. M. (1999) Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS Lett. 454, 157-164.
26. Goedert M., Spillanti M. G., Jakes R., Rutherford D. and Crowther R. A. (1989) Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
27. Goedert M., Jakes R., Qi Z., Wang J. H. and Cohen P. (1995) Protein phosphatse 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J. Neurochem. 65, 2804-2807.
28. Gong C.-X., Singh T. J., Grundke-Iqbal I. and Iqbal K. (1994a) Alzheimer disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase 2B (calcineurin). J. Neurochem. 62, 803-806.
29. Gong C.-X., Grundke-Iqbal I., Damuni Z. and Iqbal K. (1994b) Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett. 341, 94-98.
30. Gong C.-X., Grundke-Iqbal I. and Iqbal K. (1994c) Dephosphorylation of Alzheimer disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61, 765-772.
31. Gong C.-X., Shaikh S., Grundke-Iqbal I. and Iqbal K. (1996) Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics. Brain Res. 741, 95-102.
32. Gong C.-X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I. and Iqbal K. (2000) The phosphorylation state of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. J. Biol. Chem. 275, 5535-5544.
33. Grundke-Iqbal I., Iqbal K., Tung Y.-C., Quinlan M., Wisniewski H. M. and Binder L. I. (1986) Abnormal phosphorylation of the microtubulc associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913-4917.
34. Grundke-Iqbal I., Vorbrodt A. W., Iqbal K., Tung Y. C., Wang G. P. and Wisniewski H. M. (1988) Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments. Mol. Brain Res. 4, 43-52.
35. Hanger D. P., Betts J. C., Loviny T. L., Blackstock W. P. and Anderton B. H. (1998) New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J. Neurochem. 71, 2465-2476.
36. Hasegawa M., Wabanabe A., Takio K., Suzuki M., Arai T., Titani K. and Ihara Y. (1993) Characterization of two distinct monoclonal antibodies to paired helical filaments: further evidence for fetal-type phosphorylation of the tau in paired helical filaments. J. Neurochem. 60, 2068-2077.
37. Himmler A. (1989) The structure of the bovine tau gene: alternatively spliced transcripts generate a protein family. Mol. Cell. Biol. 9, 1389-1396.
38. Iqbal K., del Alonso A. C., Gondal J. A., Gong C.-X., Haque N., Khatoon S., Sengupta A., Wang J.-Z. and Grundke-Iqbal I. (2000) Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. J. Neural Transm. 59, 213-222.
39. Ishiguro, K., Shiratsuchi A., Sato S., Omori A., Aricka M., Kobayashi S., Uchida T. and Imahori K. (1993) Glycogen synthase kinase 3β is identical to tau protein kinase 1 generating several epitopes of paired helical filaments. FEBS Lett. 325, 167-172.
40. Jicha G. A., Weaver C., Lane E., Vianna C., Kres Y., Rockwood J. and Davies P. (1999) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J. Neurosci. 19, 7486-7494.
41. Johnson G. V. W. and Hartigan J. A. (1999) Tau protein in normal and Alzheimer's disease brain: An update. J. Alzheimers Dis. 1, 329-351.
42. Kandel E. R., Schwarts J. H. and Jessell T. M. (2000) Principles of Neural Science, 4th edn. McGraw-Hill Co, New York.
43. Kins S., Crameri A., Evans D. R., Hemmings B. A., Nitsch R. M. and Gotz J. (2001) Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J. Biol. Chem. 276, 38193-38200.
44. Liao H., Li Y., Brautigan D. L. and Gundersen G. G. (1998) Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau. J. Biol. Chem. 273, 21901-21908.
45. Lichtenberg-Kraag B., Mandelkow E.-M., Biemat J., Schröoter C., Gustke N., Meyer H. E. and Mandelkow E. (1992) Phosphorylation-dependent epitopes of neurofilmnent antibodies on tau protein and relationship with Alzheimer tau. Proc. Natl Acad. Sci. USA 89, 5384-5388.
46. Lindwall G. and Cole R. D. (1984) The purification of tau protein and the occurrence of two phosphorylation states of tau in brain. J. Biol. Chem. 259, 12241-12245.
47. Litersky J. M., Johnson G. V., Jakes R., Goedert M., Lee M. and Seubert P. (1996) Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem. J. 316, 655-660.
48. Liu W.-K., Moore W. T., Williams R. T., Hall F. L. and Yen S.-H. (1993) Application of synthetic phospho- and unphospho-peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease, J. Neurosci. Res. 34, 371-376.
49. Liu F., Qi H. L., Zhang Y., Zhang X. Y. and Chen H. L. (2001) Transfection of the c-erbB2/neu gene upregulates the expression of sialyl Lewis X, alpha1,3-fucosyltransferase VII, and metastatic potential in a human hepatocarcinoma cell line. Eur. J. Biochem. 268, 3501-3512.
50. Liu F., Zaidi T., Iqbal K., Grandke-Iqbal I. and Gong C.-X. (2002a) Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5. Neuroscience 115, 829-837.
51. Liu F., Iqbal K., Grandke-Iqbal I. and Gong C.-X. (2002b) Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3β. FEBS Lett. 530, 209-214.
52. Lovestone S. and Reynolds C. H. (1997) The hyperphosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78, 309-324.
53. Lubert E. J., Hong Y. and Sarge K. D. (2001) Interaction between protein phosphatase 5 and the A subunit of protein phosphatase 2A: evidence for a heterotrimeric form of protein phosphatase 5. J. Biol. Chem. 276, 38582-38587.
54. 205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J. Biol. Chem. 271, 5589-5594.
55. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Watanabe A., Titani K. and Ihara Y. (1995) Hyperphosphorylation of Tau in PHF. Neurobiol. Aging 16, 375-380.
56. Morita K., Saitoh M., Tobiume K., Matsuura H., Enomoto S., Nishitoh H. and Ichijo H. (2001) Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20, 6028-6036.
57. Otvos L., Feiner L., Lang E., Szendrei G., Goedert M. and Lee V. M. Y. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res. 39, 669-673.
58. Pei J.-J., Gong C.-X., Iqbal K., Grundke-Iqbal I., Wu Q. L., Winblad B. and Cowbum R. F. (1998) Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains. J. Neural Transm. 105, 69-83.
59. Prasad M. R., Lovell M. A., Yatin M., Dhillon H. and Maekesberry W. R. (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23, 81-88.
60. Ramsey A. J. and Chinkers M. (2002) Identification of potential physiological activators of protein phosphatase 5. Biochemistry 41, 5625-5632.
61. Reynolds C. H., Betts J. C., Blackstock W. P., Nebreda A. R. and Anderton B. H. (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74, 1587-1595.
62. Robertson J., Loviny T. L., Goedert M., Jakes R., Murray K. J., Anderton B. H. and Hanger D. P. (1993) Phosphorylation of tau by cyclic-AMP-dependent protein kinase. Dementia 4, 256-263.
63. Russell L. C., Whitt S. R., Chen M. S. and Chinkers M. (1999) Identification of conserved residues required for the binding of a tetratricopeptide repeat domain to heat shock protein 90. J. Biol. Chem. 274, 20060-20063.
64. Scott C. W., Spreen R. C., Herman J. L., Chow F. P., Davison M. D., Young J. and Caputo C. (1993) Phosphorylation of recombinant tau by cAMP-dependent protein kinase: Identification of phosphorylation sites and effect on microtubule assembly. J. Biol. Chem. 268, 1168-1173.
65. Seubert P., Mawal-Dewan M., Barbour R. et al. (1995) Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem. 270, 18917-18922.
66. Shelanski M. L., Gaskin F. and Cantor C. R. (1973) Microtubule assembly in the absence of added nucleotides. Proc. Natl Acad. Sci. USA 70, 765-768.
67. Sinclair C., Borchers C., Parker C., Tomer K., Charbonneau H. and Rossie S. (1999) The tetratricopeptide repeat domain and a C-terminal region control the activity of Ser/Thr protein phosphatase 5. J. Biol. Chem. 274, 23666-23672.
68. Skinner J., Sinclair C., Romeo C., Armstrong D., Charbonneau H. and Rossie S. (1997) Purification of a fatty acid-stimulated protein-serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5. J. Biol. Chem. 272, 22464-22471.
69. Sontag E., Nunbhakdi-Craig V., Lee G., Bloom G. S. and Mumby M. C. (1996) Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 17, 1201-1207.
70. Sontag E., Nunbhakdi-Craig V., Lee G., Brandt R., Kamibayashi C., Kuret J., White C. L., III, Mumby M. C. and Bloom G. S. (1999) Molecular interaction among protein phosphatase 2A, tau, and microtubules. J. Biol. Chem. 274, 25495-25498.
71. Tanemura K., Murayama M., Akagi T., Hashikawa T., Tominaga T., Ichikawa M., Yamaguchi H. and Takashima A. (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J. Neurosci. 22, 133-141.
72. Vallee R. B. (1986) Reversible assembly purification of micrombules without assembly-promoting agents and further purification of tubulin, micrombule-associated proteins, and MAP fragments. Meth. Enzymol. 134, 89-104.
73. Wang J. Z., Wu Q., Smith A., Grundke-Iqbal I. and Iqbal K. (1998) Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett. 436, 28-34.
74. Wilson D. M. and Binder L. I. (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am. J. Pathol. 150, 2181-2195.
75. Yamamoto H., Saitoh Y., Fukunaga K., Nishimura H. and Miyamoto E. (1988) Dephosphorylation of micrombule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly. J. Neurochem. 50, 1614-1623.